U.S. Semiconductors Stock News

MBX Biosciences (MBX) is back on investor radars after CEO P. Kent Hawryluk reported buying 18,500 additional shares as the company prepares its lead hypoparathyroidism therapy for a Phase 3 trial. See our latest analysis for MBX Biosciences. At a latest share price of $28.50, MBX has seen a 1 year total shareholder return of about 2.7x, while its 30 day share price return of 12.4% and year to date share price return of 6.7% suggest some recent cooling in momentum after a strong run into...

In March 2026, Novanta Inc. announced it had joined the NVIDIA Halos AI Systems Inspection Lab, an ANAB-accredited facility focused on validating AI-driven physical systems, to align its motion control and sensing technologies with NVIDIA safety platforms such as NVIDIA IGX Thor. This collaboration aims to make it easier for robotics and physical AI equipment makers to certify warehouse automation, industrial robotics, and emerging humanoid platforms by ensuring Novanta’s hardware and...

Recent performance snapshot eToro Group (NasdaqGS:ETOR) has drawn attention after a period of weaker share performance, with the stock showing negative returns over the past week, month, past 3 months, and year to date. For context, the shares last closed at US$29.05, while the company reports annual revenue of US$13,700.697 and net income of US$215.696 from its multi asset trading and investing platform. See our latest analysis for eToro Group. The weak recent share price return, including a...

SELLAS Life Sciences Group, Inc. filed a US$150 million at-the-market follow-on equity offering alongside a broad omnibus shelf registration covering common and preferred stock, debt securities, warrants, and units, shortly after reporting a narrower full-year 2025 net loss of US$26.86 million and lower basic loss per share. At the same time, SELLAS is highlighting preclinical data for its CDK9 inhibitor SLS009 in acute myeloid leukemia, including activity in mutation-heavy models often...

In March 2026, Kanzhun Limited reported past fourth-quarter and full-year 2025 results showing higher revenue and net income, issued first-quarter 2026 revenue guidance, approved a new annual dividend policy, and expanded its share repurchase authorization to US$400 million through August 28, 2027. The decision to return at least half of adjusted net income over the next three years via dividends and buybacks highlights a stronger emphasis on capital returns alongside Kanzhun’s core online...

Why Andersons Stock Is On Investors’ Radar Andersons (ANDE) has drawn attention after a period of strong share price performance, with the stock showing double digit total returns over the past year and the past three months. See our latest analysis for Andersons. With the share price at $73.19, Andersons has seen strong momentum, with a 10.16% 7 day share price return and a 12.10% 30 day share price return. The 1 year total shareholder return of 72.35% highlights how sustained this trend has...

TPG (TPG) shares were in focus after reports that OpenAI is in advanced talks with the firm and other private equity groups to create a joint venture to distribute OpenAI’s enterprise products. See our latest analysis for TPG. The OpenAI talks arrive during a weak patch for TPG’s share price, which has a 1 month share price return of 9.95% and a year to date share price return of 40.53%, even though the 3 year total shareholder return is 49%. This suggests that longer term holders have still...

Pony AI (PONY) is back in focus after reporting mixed fourth quarter results, with revenue of US$29.13 million, net income of US$23.43 million, and a new robotaxi partnership in Europe with Uber and Verne. See our latest analysis for Pony AI. The earnings release and new robotaxi partnerships arrive after a sharp pullback in the share price, with a 30 day share price return of a 36.26% decline and a year to date share price return of a 43.12% decline, even as the 1 year total shareholder...

Rocket Pharmaceuticals (RCKT) is back in focus after the FDA granted accelerated approval for its gene therapy KRESLADI to treat pediatric patients with severe leukocyte adhesion deficiency I who lack matched sibling donors. See our latest analysis for Rocket Pharmaceuticals. Even with the FDA approval and accompanying priority review voucher, Rocket Pharmaceuticals’ recent share price performance has been weak, with a 1-month share price return of a 24.75% decline and a 1-year total...

In March 2026, MACOM Technology Solutions Inc. announced new 448G PAM4 modulator drivers and joined Broadcom, Cisco, NVIDIA and Semtech in forming the 400G Optical MSA to define interoperable 400G-per-wavelength interfaces for next-generation AI data center equipment. This combination of higher-speed optical components and participation in an industry standards group positions MACOM at the heart of emerging AI infrastructure connectivity, even as US-China trade tensions add uncertainty for...

Green Plains (GPRE) has drawn fresh attention as investors reassess its role in low carbon fuels, with recent returns over the month and past 3 months prompting closer scrutiny of its fundamentals. See our latest analysis for Green Plains. At a share price of $16.89, Green Plains has seen a 30 day share price return of 23.02% and a 90 day share price return of 71.47%. Its 1 year total shareholder return of 247.53% contrasts with weaker 3 and 5 year total shareholder returns, suggesting strong...

Monte Rosa Therapeutics, Inc. recently reported a fourth-quarter 2025 net loss of US$46.14 million and entered a supply agreement with Johnson & Johnson to evaluate its investigational molecular glue degrader MRT-2359 in combination with ERLEADA in a planned Phase 2 study for metastatic castration-resistant prostate cancer. This collaboration, together with positive early data for MRT-2359 presented at the 2026 ASCO GU Cancers Symposium, highlights growing external interest in Monte Rosa’s...

Celcuity (CELC) has been in focus after the FDA accepted its New Drug Application for gedatolisib with priority review, while management simultaneously accelerates commercial preparation ahead of a potential launch. See our latest analysis for Celcuity. The share price has been volatile around these updates, with a 1 day share price return of negative 7.66% and a 30 day share price return of negative 5.09%. However, the 1 year total shareholder return is very large and indicates that longer...

Diversified Energy recently announced a new share buyback program running through March 2027, targeting the repurchase of about 7.8 million shares and disclosing a completed buyback of 300,000 shares, while President and CFO Bradley Gray gifted 15,000 shares to family members, reducing his beneficial ownership to 212,790 shares. This combination of an expanded capital return plan and updated insider holdings offers fresh insight into how management is currently aligning with...

On March 18, 2026, Genuine Parts Company announced that Executive Vice President and Chief Information & Digital Officer Naveen Krishna had resigned, stepping down as an executive officer on April 1 while remaining until May 5 to support a transition, with his duties to be redistributed and no severance paid. The decision not to appoint a direct successor and instead spread Krishna’s responsibilities across existing leaders raises questions about how Genuine Parts will maintain momentum in...

National Fuel Gas (NYSE:NFG) entered into a new US$1.3b unsecured committed revolving credit facility with a group of major lenders. The new facility extends the company’s debt maturity profile to 2031 and amends prior credit agreements. Management plans to use the facility for repaying existing debt, general corporate purposes, and potential future investments. National Fuel Gas, a diversified energy company involved in natural gas exploration, production, gathering, and distribution, now...

Howmet Aerospace recently reported upbeat fiscal fourth-quarter results and raised its first-quarter profit guidance above analyst expectations, while also gaining visibility as one of Jim Cramer’s highlighted defense technology names. This combination of stronger-than-anticipated guidance and growing recognition for its role in supplying critical aerospace and defense components has sharpened investor focus on Howmet’s earnings power and industry positioning. Now we’ll explore how this...

Recent share performance and business snapshot Fortive (FTV) shares have retreated over the past month and past 3 months, with returns of 8.9% and 4.0% respectively. This has prompted some investors to reassess the company’s fundamentals and recent financial profile. The group generates revenue of about US$4.16b and net income of roughly US$532.7m. Its operations are split between its Intelligent Operating Solutions and Advanced Healthcare Solutions segments across the United States, Asia...

Kymera Therapeutics recently reported past positive Phase 1b data for KT-621, its first-in-class oral STAT6 degrader in moderate-to-severe atopic dermatitis, showing deep STAT6 reduction, broad biomarker effects and encouraging clinical improvements after 28 days of once-daily dosing. The data, presented as a late-breaking oral session at the American Academy of Dermatology meeting, highlight how Kymera’s protein degradation platform may translate into biologics-like immune modulation using...

JonnyPops is rolling out its Organic Water Pops to more than 1,800 Albertsons Companies (ACI) stores nationwide, expanding Albertsons frozen assortment with branded better-for-you treats aimed at families shopping the frozen aisle. See our latest analysis for Albertsons Companies. Albertsons Companies’ recent news on expanding better-for-you frozen treats comes against a backdrop of a 4.64% 1 month share price decline and a 1 year total shareholder return fall of 18.59%, while the 5 year...

Recent share performance and business snapshot Versant Media Group (VSNT) has caught investor attention after a mixed stretch in the share price, with gains over the past month contrasting with weaker returns in the past 3 months and year to date. The company operates a media and entertainment portfolio focused on U.S. television programming and distribution. It has reported revenue of US$6,688 and net income of US$930, and is positioned as a mid cap name around US$5.1b. See our latest...

If you are wondering whether International Paper at around US$35.45 is a bargain or a value trap, you are not alone. This article is built to help you think that through clearly. The stock has moved 5.0% over the last 7 days, while returns of an 18.6% decline over 30 days and an 11.9% decline year to date, alongside a 30.6% decline over the past year, show how quickly sentiment around the shares can change. Recent coverage has focused on how International Paper fits into the broader...

Wondering whether General Mills at around US$36.45 is starting to look like value or still has more room to fall? This article focuses on what the current price really implies. The stock has seen sharp moves recently, with a 1.5% decline over the last week, a 19.4% decline over the last month, a 20.3% decline year to date and a 35.2% decline over the last year. The 3 year and 5 year returns sit at 52.0% and 28.5% declines respectively. These price moves have kept General Mills in focus as...

Wondering whether Leggett & Platt at around US$9.58 is a bargain or a value trap? This article walks you through what the current price might really be saying. The stock has recently shown mixed returns, with a 0.3% move over the last week, an 18.0% decline over the last month, a 12.8% decline year to date, a 22.4% gain over the last year, and longer term declines of 66.4% over three years and 74.7% over five years. Recent coverage has focused on Leggett & Platt's share price swings and what...